Reports
Reports
Sale
The report gives an in-depth analysis of the key players involved in the angiography devices market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
Angiography devices Market Size
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.1.1 Research Objectives
1.1.2 Key Findings of the Report
1.2 Limitations of the Study and Scope for Future Research
2 Research Methodology
3 Executive Summary
4 Global Angiography Devices Market
4.1 Global Angiography Devices Market Overview
4.2 Global Angiography Devices Market Analysis
4.2.1 Market Overview
4.2.1.1 Global Angiography Devices Market Historical Value (2017-2023)
4.2.1.2 Global Angiography Devices Market Forecast Value (2024-2032)
4.3 Global Angiography Devices Market by Product
4.3.1 Market Overview
4.3.1.1 Angiography Systems
4.3.1.2 Balloons
4.3.1.3 Catheters
4.3.1.4 Contrast Media
4.3.1.5 Guidewire
4.3.1.6 Vascular Closure Devices
4.3.1.7 Angiography Accessories
4.3.1.8 Others
4.4 Global Angiography Devices Market by Indication
4.4.1 Market Overview
4.4.1.1 Cerebral
4.4.1.2 Carotid
4.4.1.3 Peripheral
4.4.1.4 Aortic
4.4.1.5 Coronary
4.4.1.6 Others
4.5 Global Angiography Devices Market by Application
4.5.1 Market Overview
4.5.1.1 Diagnostics
4.5.1.1.1 X-Rays
4.5.1.1.2 Computed Tomography (CT)
4.5.1.1.3 Magnetic Resonance Angiography (MRA)
4.5.1.2 Therapeutics
4.5.1.2.1 Coronary Angiography
4.5.1.2.2 Micro Angiography
4.5.1.2.3 Non-Coronary Angiography
4.5.1.2.3.1 Neurovascular Angiography
4.5.1.2.3.2 Peripheral Angiography
4.5.1.3 Others
4.6 Global Angiography Devices Market by Distribution Channels
4.6.1 Market Overview
4.6.1.1 Hospitals
4.6.1.2 Diagnostic Centers
4.6.1.3 Research Laboratories
4.7 Global Angiography Devices Market by Region
4.7.1 Market Overview
4.7.1.1 North America
4.7.1.2 Europe
4.7.1.3 Asia Pacific
4.7.1.4 Latin America
4.7.1.5 Middle East and Africa
4.7.2 North America
4.7.2.1 Historical Trend (2017-2023)
4.7.2.2 Forecast Trend (2024-2032)
4.7.2.3 Break Up by Country
4.7.2.3.1 United States of America
4.7.2.3.2 Canada
4.7.3 Europe
4.7.3.1 Historical Trend (2017-2023)
4.7.3.2 Forecast Trend (2024-2032)
4.7.3.3 Break Up by Country
4.7.3.3.1 United Kingdom
4.7.3.3.2 Germany
4.7.3.3.3 France
4.7.3.3.4 Italy
4.7.3.3.5 Others
4.7.4 Asia Pacific
4.7.4.1 Historical Trend (2017-2023)
4.7.4.2 Forecast Trend (2024-2032)
4.7.4.3 Break Up by Country
4.7.4.3.1 China
4.7.4.3.2 Japan
4.7.4.3.3 India
4.7.4.3.4 ASEAN
4.7.4.3.5 Australia
4.7.4.3.6 Others
4.7.5 Latin America
4.7.5.1 Historical Trend (2017-2023)
4.7.5.2 Forecast Trend (2024-2032)
4.7.5.3 Break Up by Country
4.7.5.3.1 Brazil
4.7.5.3.2 Argentina
4.7.5.3.3 Mexico
4.7.5.3.4 Others
4.7.6 Middle East and Africa
4.7.6.1 Historical Trend (2017-2023)
4.7.6.2 Forecast Trend (2024-2032)
4.7.6.3 Break Up by Country
4.7.6.3.1 Saudi Arabia
4.7.6.3.2 United Arab Emirates
4.7.6.3.3 Nigeria
4.7.6.3.4 South Africa
4.7.6.3.5 Others
5 Trade Data Analysis by HS Code
5.1 Angiography Diagnostic System- 90189019
5.2 Cardiac and Vascular Angiography System - 90189099
6 Current Scenario Evaluation and Regulatory Framework
6.1 Emerging Therapies and Clinical Trials Synopsis
6.2 Patent Landscape
6.2.1 Patent Overview
6.2.1.1 Patent Status and Expiry
6.2.1.2 Timelines from Device Development to Commercial Launch
6.2.1.3 New Device Application
6.2.1.3.1 Documentation and Approval Process
6.3 Cost of Treatment
6.4 Regulatory Framework
6.4.1 Regulatory Overview
6.4.1.1 US FDA
6.4.1.2 EU EMA
6.4.1.3 INDIA CDSCO
6.4.1.4 JAPAN PMDA
6.4.1.5 Others
7 Global Angiography Devices Market Dynamics
7.1 Market Drivers and Constraints
7.2 SWOT Analysis
7.3 Porter’s Five Forces Model
7.4 Key Demand Indicators
7.5 Key Price Indicators
7.6 Industry Events, Initiatives, and Trends
7.7 Value Chain Analysis
8 Supplier Landscape
8.1 Siemens AG
8.1.1 Company Overview
8.1.2 Product Portfolio
8.1.3 Demographic Reach and Achievements
8.1.4 Mergers and Acquisitions
8.1.5 Certifications
8.2 Canon Medical Systems Corporation
8.2.1 Company Overview
8.2.2 Product Portfolio
8.2.3 Demographic Reach and Achievements
8.2.4 Mergers and Acquisitions
8.2.5 Certifications
8.3 Medtronic plc
8.3.1 Company Overview
8.3.2 Product Portfolio
8.3.3 Demographic Reach and Achievements
8.3.4 Mergers and Acquisitions
8.3.5 Certifications
8.4 Koninklijke Philips N.V.
8.4.1 Company Overview
8.4.2 Product Portfolio
8.4.3 Demographic Reach and Achievements
8.4.4 Mergers and Acquisitions
8.4.5 Certifications
8.5 Boston Scientific Corporation
8.5.1 Company Overview
8.5.2 Product Portfolio
8.5.3 Demographic Reach and Achievements
8.5.4 Mergers and Acquisitions
8.5.5 Certifications
8.6 Johnson & Johnson
8.6.1 Company Overview
8.6.2 Product Portfolio
8.6.3 Demographic Reach and Achievements
8.6.4 Mergers and Acquisitions
8.6.5 Certifications
8.7 Abbott Laboratories
8.7.1 Company Overview
8.7.2 Product Portfolio
8.7.3 Demographic Reach and Achievements
8.7.4 Mergers and Acquisitions
8.7.5 Certifications
8.8 Cook Group Incorporated
8.8.1 Company Overview
8.8.2 Product Portfolio
8.8.3 Demographic Reach and Achievements
8.8.4 Mergers and Acquisitions
8.8.5 Certifications
8.9 General Electric Company
8.9.1 Company Overview
8.9.2 Product Portfolio
8.9.3 Demographic Reach and Achievements
8.9.4 Mergers and Acquisitions
8.9.5 Certifications
8.10 Shimadzu Corporation
8.10.1 Company Overview
8.10.2 Product Portfolio
8.10.3 Demographic Reach and Achievements
8.10.4 Mergers and Acquisitions
8.10.5 Certifications
8.11 St. Jude Medical
8.11.1 Company Overview
8.11.2 Product Portfolio
8.11.3 Demographic Reach and Achievements
8.11.4 Mergers and Acquisitions
8.11.5 Certifications
8.12 B. Braun Melsungen AG
8.12.1 Company Overview
8.12.2 Product Portfolio
8.12.3 Demographic Reach and Achievements
8.12.4 Mergers and Acquisitions
8.12.5 Certifications
8.13 GE Healthcare
8.13.1 Company Overview
8.13.2 Product Portfolio
8.13.3 Demographic Reach and Achievements
8.13.4 Mergers and Acquisitions
8.13.5 Certifications
8.14 Cardinal Health, Inc.
8.14.1 Company Overview
8.14.2 Product Portfolio
8.14.3 Demographic Reach and Achievements
8.14.4 Mergers and Acquisitions
8.14.5 Certifications
9 Recommendations and Discussion
10 Pricing Models and Strategies (Additional Insight)
10.1 Overview
10.2 Cost Model
10.2.1 Manufacturing Cost Analysis
10.2.2 Procurement Cost Analysis
10.2.3 Clinical Trial Cost Factors
10.3 Pricing Strategies
10.3.1 Competitor Pricing Analysis
10.3.2 Key Assessment of Product Attributes
10.3.3 Pricing Benchmark
11 Global Angiography Devices Distribution Model (Additional Insight)
11.1 Overview
11.2 Potential Distributors
11.3 Key Parameters for Distribution Partner Assessment
*Additional insights provided are customisable as per client requirements.
The rising cardiovascular cases, technological advancements, and increased expenditure in the research and developmental sector are the key factors responsible for driving this market growth.
Based on the product, the market is segmented into angiography systems, balloons, catheters, contrast media, guidewire, vascular closure devices, and angiography accessories, among others.
Based on the application, the market is divided into the diagnostics and therapeutics sectors, among others.
Cardiovascular segment accounts for the highest share in this market.
The different regions are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America accounts for the highest share of this market.
The distribution channels in this market are hospitals, research laboratories, and diagnostic centres.
Based on indication, the market can be divided into cerebral, carotid, peripheral, aortic, and coronary, among others.
Angiography is a medical imaging technique assisting in the diagnosis and treatment of several disorders.
The equipment used in the angiography include radiographic table, X-ray tubes, and visual monitors.
The key players in this market are Siemens AG, Canon Medical Systems Corporation, Medtronic plc, Koninklijke Philips N.V., Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories, Cook Group Incorporated, General Electric Company, Shimadzu Corporation, St. Jude Medical, B. Braun Melsungen AG, GE Healthcare, and Cardinal Health, Inc., among others.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.